Related Articles
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report
Circulating tumor DNA analysis of metastatic renal cell carcinoma
Comprehensive analysis of genomic alterations detected by next‑generation sequencing‑based tissue and circulating tumor DNA assays in Chinese patients with non‑small cell lung cancer
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer